1,300 Shares in Proto Labs, Inc. (NYSE:PRLB) Bought by Innealta Capital LLC

Innealta Capital LLC purchased a new stake in shares of Proto Labs, Inc. (NYSE:PRLB) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 1,300 shares of the industrial products company’s stock, valued at approximately $40,000.

A number of other large investors have also added to or reduced their stakes in PRLB. Norges Bank bought a new position in shares of Proto Labs during the fourth quarter valued at about $11,382,000. Assenagon Asset Management S.A. bought a new stake in shares of Proto Labs in the second quarter worth about $7,535,000. Hillsdale Investment Management Inc. purchased a new stake in Proto Labs in the fourth quarter worth about $3,911,000. Jupiter Asset Management Ltd. lifted its holdings in Proto Labs by 89.3% in the first quarter. Jupiter Asset Management Ltd. now owns 147,011 shares of the industrial products company’s stock worth $5,256,000 after buying an additional 69,347 shares during the period. Finally, Partnership Wealth Management LLC purchased a new position in shares of Proto Labs during the fourth quarter valued at approximately $2,445,000. Hedge funds and other institutional investors own 84.54% of the company’s stock.

Proto Labs Stock Up 1.9 %

NYSE:PRLB traded up $0.57 during mid-day trading on Friday, hitting $30.60. 279,673 shares of the stock traded hands, compared to its average volume of 172,684. The stock has a market capitalization of $774.67 million, a price-to-earnings ratio of 39.00 and a beta of 1.33. Proto Labs, Inc. has a 52 week low of $23.01 and a 52 week high of $41.87. The firm’s 50 day moving average is $31.02 and its two-hundred day moving average is $32.47.

Proto Labs (NYSE:PRLB) last issued its quarterly earnings results on Friday, August 2nd. The industrial products company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.35 by $0.03. The company had revenue of $125.60 million for the quarter, compared to the consensus estimate of $126.25 million. Proto Labs had a net margin of 4.86% and a return on equity of 3.60%. The firm’s revenue was up 2.7% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.01) EPS. As a group, research analysts predict that Proto Labs, Inc. will post 0.7 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on PRLB. StockNews.com lowered shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a report on Monday, August 5th. Needham & Company LLC reaffirmed a “hold” rating on shares of Proto Labs in a research report on Monday, August 5th. Benchmark reaffirmed a “buy” rating and issued a $45.00 target price on shares of Proto Labs in a research report on Wednesday, May 29th. Craig Hallum cut their target price on shares of Proto Labs from $38.00 to $34.00 and set a “hold” rating for the company in a research report on Monday, May 6th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $44.00 price objective on shares of Proto Labs in a research report on Tuesday, July 30th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, Proto Labs has a consensus rating of “Moderate Buy” and a consensus target price of $41.00.

About Proto Labs

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.